Crescita Therapeutics Inc (CTX) — Cash Flow Quality Index
Crescita Therapeutics Inc (CTX) has a Cash Flow Quality Index of 1.56x as of September 2025. Operating cash flow of CA$1.17 Million exceeds net income of CA$753.00K, indicating high earnings quality where cash backs reported profits. Explore cash efficiency ratio of Crescita Therapeutics Inc to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Crescita Therapeutics Inc Cash Flow Quality Index (2018–2022)
Historical Cash Flow Quality Index for Crescita Therapeutics Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Crescita Therapeutics Inc (CTX) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Crescita Therapeutics Inc (2018–2022)
Year-by-year earnings quality comparison for Crescita Therapeutics Inc. For live market cap and the full company financial profile, see Crescita Therapeutics Inc market capitalisation.
| Year | Quality Index | Operating CF (CAD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -1.18x | CA$-1.02 Million | CA$862.00K | ▼ -100.8% |
| 2020 | 151.57x | CA$5.61 Million | CA$37.00K | ▲ +5198.9% |
| 2019 | 2.86x | CA$5.31 Million | CA$1.85 Million | ▲ +563.7% |
| 2018 | -0.62x | CA$-1.48 Million | CA$2.40 Million | — |